Skip to main content

Captrust Financial Advisors

SEC CIK
0001512024
Latest filing
Aug 13, 2026

XENE holding history

Xenon Pharmaceuticals Inc. in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

XENE overviewAll 13F holders of XENEFull Q2 2026 holdings

Shares (Q2 2026)
5,572
Value
$336.3K
% of portfolio
<0.1%
Quarters held
2
Since Q3 2021
Holdings of XENE by Captrust Financial Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,572$336.3K<0.1%+5,572NewHolders
Q4 20210$00.0%−3,000−100.0%Sold outHolders
Q3 20213,000$46.0K<0.1%+3,000NewHolders